Category: In Vitro

Molecular Biometrics pulls in $12.5 million Series B round

January 12, 2010 by MassDevice staff

Molecular Biometrics Inc. pulled in $12.5 million in a Series B round to commercialize its diagnostic test designed to identify viable embryos for in vitro fertilization procedures.

Molecular Biometrics Inc. pulled in $12.5 million in Series B financing, led by new investor Atlas Venture.

The Norwood, Mass.-based firm is working on a diagnostic to determine the most viable embryos for use in in vitro fertilization procedures, with an eye toward reducing the risk of multiple births and improving IVF pregnancy rates.

Zoiray Technologies

8 St. Mary's St

Ste 611

Boston

02215

United States

(617) 358-6003

www.zoiray.com

Product(s):

Develops multiplex immunoassay platform for clinical diagnostics

Employees:

Established:

2008

CEO:

David Bergstein

Management:

Linda Smith, VP Marketing

Hologic takes a very tangible, $2.3 billion Q2 hit

May 4, 2009 by MassDevice staff

Bedford women's health products maker takes a massive second-quarter write-down on intangible assets and goodwill for its Cytyc and Third Wave acquisitions.

Hologic Inc. posted a massive second-quarter loss after taking a $2.34 billion write-down of goodwill and intangible assets on its acquisitions of Cytyc and Third Wave Technologies.

THe Bedford-based women's health products maker's stock slipped more than 10 percent in after-hours trading today, to $14 per share, after posting a high of $15.72 during the day.

Inverness to market TechLab rapid test for C. difficile infections

March 30, 2009 by MassDevice staff

Waltham diagnostics manufacturer to bring Blacksburg, Va.-based diagnostics developer's test for Clostridium difficile associated disease to market.

Inverness Medical Innovations Inc. will begin selling a rapid diagnostic test for Clostridium difficile associated disease developed by TechLab Inc.

The Blacksburg, Va.-based diagnostics developer, a 1989 spinoff from Virginia Tech's Anaerobe Laboratory, developed the in vitro diagnostic to detect CDAD, a highly infectious cause of severe diarrhea and colitis that can kill elderly or immune-compromised patients.

The federal Food & Drug Administration recently cleared TechLab to make the C. Diff Quik Chek Complete test, which reveals results in 30 minutes, for the Waltham-based diagnostics maker.